Holen Sie sich die Stockscreener-App
0.24
24.51%
-0.0713
Handel nachbörslich:
.24
Schlusskurs vom Vortag:
$0.3113
Offen:
$0.24738
24-Stunden-Volumen:
9,008
Relative Volume:
66.00
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
$-25.70M
KGV:
-0.0475
EPS:
-5.0543
Netto-Cashflow:
$-5.93M
1W Leistung:
-24.51%
1M Leistung:
-62.29%
6M Leistung:
-84.44%
1J Leistung:
-93.80%
1-Tages-Spanne:
$0.24
$0.2474
1-Wochen-Bereich:
$0.24
$0.2474
52-Wochen-Spanne:
$0.24
$0.2474
Zyversa Therapeutics Inc Stock (ZVSA) Company Profile
Firmenname
Zyversa Therapeutics Inc
Sektor
Branche
Telefon
-
Adresse
-
Compare ZVSA vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZVSA
Zyversa Therapeutics Inc
|
0.24 | 0 | 0 | -25.70M | -5.93M | -5.0543 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Zyversa Therapeutics Inc Aktie (ZVSA) Neueste Nachrichten
Retail Traders Flock To ZyVersa As IC 100 Obesity Plan Looks To Fill GLP-1 Gaps - MSN
ZyVersa Therapeutics Announces $1 Million Convertible Note Financing - TipRanks
Does ZyVersa Therapeutics Inc meet Warren Buffetts criteriaRecession Risk & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
ZyVersa Therapeutics, Inc. announced that it has received $1 million in funding - marketscreener.com
Trading Recap: What makes NAGE stock attractive todayRecession Risk & Real-Time Chart Pattern Alerts - baoquankhu1.vn
ZVSA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Market Review: Is ZyVersa Therapeutics Inc a strong candidate for buy and holdNew Guidance & Daily Chart Pattern Signal Reports - baoquankhu1.vn
Is ZyVersa Therapeutics Inc. a good ESG investmentTake Profit & High Conviction Buy Zone Picks - mfd.ru
How ZyVersa Therapeutics Inc. stock performs in interest rate cyclesJuly 2025 Reactions & Expert Curated Trade Ideas - mfd.ru
Will ZyVersa Therapeutics Inc. benefit from rising consumer demandInsider Buying & Real-Time Volume Triggers - mfd.ru
Will ZyVersa Therapeutics Inc. stock attract more institutional investors2025 Major Catalysts & Long-Term Growth Stock Strategies - mfd.ru
Can ZyVersa Therapeutics Inc. stock outperform in 2025 bull marketWeekly Profit Summary & Growth Focused Stock Pick Reports - mfd.ru
Published on: 2026-02-10 10:41:46 - baoquankhu1.vn
Macro Review: Whats the profit margin of ZyVersa Therapeutics IncEntry Point & Precise Trade Entry Recommendations - baoquankhu1.vn
Insider Sell: Will ZyVersa Therapeutics Inc benefit from rising consumer demandJuly 2025 Update & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Buyback Watch: What is the target price for ZyVersa Therapeutics Inc stockMarket Risk Report & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Aug Technicals: Is ZyVersa Therapeutics Inc stock influenced by commodity pricesJuly 2025 Selloffs & Safe Entry Point Alerts - baoquankhu1.vn
Returns Recap: What is RumbleOn Incs revenue forecastEntry Point & Smart Money Movement Alerts - baoquankhu1.vn
VIX Spike: Will ZyVersa Therapeutics Inc stock outperform tech sector in 2025Quarterly Profit Report & Consistent Return Strategy Ideas - Bộ Nội Vụ
Street Watch: Whats the profit margin of ZyVersa Therapeutics IncJuly 2025 Closing Moves & Fast Exit Strategy with Risk Control - baoquankhu1.vn
What dividend safety score for ZyVersa Therapeutics Inc. stockJuly 2025 Gainers & Smart Swing Trading Alerts - ulpravda.ru
Will ZyVersa Therapeutics Inc. stock outperform international peersMarket Trend Report & Free Risk Controlled Daily Trade Plans - ulpravda.ru
ZyVersa Therapeutics (NASDAQ:ZVSA) Shares Up 65.4% – Still a Buy? - Defense World
ZyVersa Therapeutics, Inc.Common Stock (NQ: ZVSA - FinancialContent
What catalysts could drive ZyVersa Therapeutics Inc. stock higherWeekly Investment Report & AI Driven Stock Movement Reports - Улправда
Will ZyVersa Therapeutics Inc. stock benefit from infrastructure spending2025 Buyback Activity & Weekly Watchlist for Hot Stocks - Улправда
Why ZyVersa Therapeutics Inc. stock could rally in 2025Weekly Gains Report & Growth Focused Entry Reports - Улправда
Can ZyVersa Therapeutics Inc. stock sustain market leadership2025 Stock Rankings & AI Forecasted Entry and Exit Points - ulpravda.ru
Will ZyVersa Therapeutics Inc. stock maintain momentum in 20252025 Support & Resistance & Fast Entry High Yield Stock Tips - Улправда
Trio Petroleum Corp. Common Stock (NY: TPET - FinancialContent
ZyVersa Therapeutics Inc Stock Analysis and ForecastRisk Adjusted Returns & Big Gains Low Cost - earlytimes.in
ZyVersa Therapeutics, Inc. (ZVSA) - Zacks Investment Research
Is ZyVersa Therapeutics Inc. stock positioned for digital transformationWeekly Stock Summary & Real-Time Market Sentiment Reports - Улправда
Investment Report: How risky is ZyVersa Therapeutics Inc stock nowWeekly Market Report & Daily Momentum Trading Reports - moha.gov.vn
Is ZyVersa Therapeutics Inc. stock a buy for dividend growthDollar Strength & Fast Entry High Yield Stock Tips - Newser
[8-K] ZyVersa Therapeutics, Inc. Reports Material Event | ZVSA SEC FilingForm 8-K - Stock Titan
ZyVersa Therapeutics Delays 10-Q Filing - MSN
Is ZyVersa Therapeutics Inc. stock safe for conservative investorsTrade Risk Assessment & Free High Return Stock Watch Alerts - newser.com
Zyversa Therapeutics Faces Financial Challenges Amid Drug Development - TipRanks
What institutional flow reveals about ZyVersa Therapeutics Inc.Trade Entry Summary & Fast Gaining Stock Strategy Reports - newser.com
A activityEntry Point & AI Powered Buy/Sell Recommendations - newser.com
ZyVersa Therapeutics Reports Third Quarter 2025 Financial Results - The Manila Times
[10-Q] ZyVersa Therapeutics, Inc. Quarterly Earnings Report | ZVSA SEC FilingForm 10-Q - Stock Titan
ZyVersa Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
ZyVersa Therapeutics Inc. stock volume spike explainedPrice Action & Free Technical Confirmation Trade Alerts - newser.com
ZyVersa Therapeutics, Inc. SEC 10-Q Report - TradingView
Finanzdaten der Zyversa Therapeutics Inc-Aktie (ZVSA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.48%
1.21%
Kapitalisierung:
|
Volumen (24h):